Citations 1
P905: PATIENT REPORTED OUTCOMES IN TRIPLE CLASS EXPOSED, RELAPSED/REFRACTORY MULTIPLE MYELOMA (TCE RRMM) PATIENTS IN KARMMA 3 TRIAL (PHASE 3 RCT): IDECABTAGENE VICLEUCEL (IDE-CEL) VERSUS STANDARD REGIMENS
Delforge, Michel , Patel, Krina K. , Eliason, Laurie , Dhanda, Devender , Shi, Ling , Guo, Shien, Arnulf, Bertrand , Manier, Salomon , McKiver, Mihaela Popa, Marshall, Thomas, Cavo, Michèle , Nooka, Ajay K. , Callander, Natalie S. , Giralt, Sergio , Einsele, Hermann , Ailawadhi, Sikander , Cook, Mark , Rodríguez‐Otero, Paula
HemaSphere | August 22, 2023 | Volume: 7 | Issue: S3 | Pages: e031009e
